The management of epilepsy during pregnancy may present problems for both the mother and the fetus. Evidence for any effect of the newer antiepileptic on the fetus is particular scanty. Limited data have not so far suggested a significant increase in risk with Levetiracetam.
Levetiracetam is transferred into breast milk in significant amounts. but serum concentrations in breast-fed infants are very low.